Mobile Cardiac Outpatient Telemetry for Unexplained Syncope
Status unknown · Not applicable · NCT05957315
Conditions: Syncope, Arrhythmia, Near Syncope, Arrhythmias, Cardiac
At a glance
- Research payments reported, 2025
- $14,000
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 160
About the trial
- Sponsor
- Carilion Clinic
- Tested
- Mobile Cardiac Outpatient Telemetry Device (MCOT) (device)
- Dates
- Started 2023-09-01; completion 2025-10-01
- Results posted
- Not yet
This study seeks to provide evidence that use of Philips mobile cardiac outpatient telemetry (MCOT) devices may improve patient care for patients who present to emergency departments (EDs) with syncope, which is a temporary loss of consciousness also known as fainting or who present experiencing a near temporary loss of consciousness (near syncope). It is set up as a random controlled trial, which means research participants will be randomly assigned to receiving the device or usual care. Patients 50 years or older who come to the ED of Carilion Roanoke Memorial Hospital will be screened by study team members for unexplained syncope or near syncope across three ED dispositions: hospital a…
From ClinicalTrials.gov, last updated 2023-07-24. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $14,000 in research payments for this study in 2025 (1 payments).
Products named: Ambulatory Monitoring & Diagnostics Undivided
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.